Clinical and Biomedical SciencesClinical and Biomedical SciencesMonogenic Diabetes Training Course 2026DescriptionThe October course is now FULL and registrations are closed. Unfortunately, our October course is now fully booked and we are unable to take any late registrations. Although the course is delivered virtually, we have had to cap the number of attendees to ensure that everyone has the opportunity to ask questions and get the most out of the experience. We have now reached our limit of over 500 delegates. We are planning to run our next course on 9–10 March 2027. An email containing the booking links should be sent to everyone on our mailing list within the next couple of weeks.
We are pleased to announce that we will be running another Virtual Monogenic Diabetes Training Course in 2026: “Right Diagnosis, Right Treatment”, hosted by Professor Andrew Hattersley and Professor Maggie Shepherd. The course will be held online over two days on Monday 19th October and Tuesday 20th October 2026. The course will start at 09:00am - 16:00 GMT on both days. This training is aimed at consultants, specialist registrars (SpRs), and experienced diabetes specialist nurses (DSNs), and others interested in ensuring their patients have the correct diagnosis and treatment. It is designed to support clinicians in recognising and managing patients with MODY and other forms of monogenic diabetes. This is a virtual event, access links will be emailed out the week before the event
Monogenic Diabetes Training Course 2027DescriptionFollowing the overwhelming popularity of our October 2026 course, which sold out, we are delighted to announce that registrations are now open for our 2027 Virtual Monogenic Diabetes Training Course, "Right Diagnosis, Right Treatment," hosted by Professor Andrew Hattersley and Professor Maggie Shepherd. The course will be held online over two days on Tuesday 9th March and Wednesday 10th Marh 2027 This training is aimed at consultants, specialist registrars (SpRs), and experienced diabetes specialist nurses (DSNs), and others interested in ensuring their patients have the correct diagnosis and treatment. It is designed to support clinicians in recognising and managing patients with MODY and other forms of monogenic diabetes.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
